Inside a most cancers analysis laboratory on the campus of Harvard Medical College, two dozen small jars with pink plastic lids sat on a metallic counter. Inside these humble-looking jars is the core of Joan Brugge’s present multiyear analysis mission.
Brugge lifted up one of many jars and gazed at it with reverence. Every jar holds samples of breast tissue donated by sufferers after they underwent a tissue biopsy or breast surgical procedure — samples which will reveal a brand new option to stop breast most cancers.
Brugge and her analysis workforce have analyzed the cell construction of greater than 100 samples.
Utilizing high-powered microscopes and complicated pc algorithms, they diagram every stage within the improvement of breast most cancers: from the primary signal of cell mutation to the formation of tiny clusters, effectively earlier than they’re giant sufficient to be thought of tumors.
Their quest is to forestall breast most cancers, a illness that afflicts roughly 1 in 8 U.S. girls over their lifetimes, in addition to some males. Their final aim is to alleviate the ache, struggling, and danger of loss of life that accompany this illness. And their painstaking work, unspooling throughout six years of a seven-year, $7 million federal grant, has yielded outcomes.
In late 2024, Brugge and her colleagues recognized particular cells in breast tissue that include the genetic seeds of breast tumors.
They usually found that these “seed cells” are surprisingly widespread. In reality, they’re current within the regular, wholesome tissue of each breast pattern her lab has examined, Brugge mentioned, together with samples from sufferers who have not had breast most cancers however have had surgical procedure for different causes, reminiscent of breast discount or a biopsy that proved benign.
The following analysis problem for Brugge’s lab is evident: Discover methods to detect, isolate, and terminate the mutant cells earlier than they will unfold and type tumors.
“I’m enthusiastic about what we’re doing proper now,” Brugge mentioned. “I believe we may make a distinction, so I don’t wish to cease.”
Work in Brugge’s lab slowed considerably final 12 months. In April, her $7 million grant from the Nationwide Most cancers Institute on the Nationwide Institutes of Well being was frozen, together with nearly all different federal cash awarded to Harvard researchers.
The Trump administration mentioned it was withholding the funds over the college’s dealing with of antisemitism on campus.
A few of Brugge’s lab workers misplaced federal fellowships that funded their work. Brugge advised others funded by the NIH grant that she couldn’t assure their salaries. In all, Brugge misplaced seven of her 18 lab workers.
In September, the funding for the NIH grant was restored. However within the intervening months, the Trump administration mentioned Brugge and different Harvard researchers needn’t hassle making use of for the subsequent spherical of multiyear grants.
A federal decide lifted that ban, however Brugge had missed the deadline to use for renewal. So her present funding will finish in August.
Brugge scrambled to safe non-public funding from foundations and philanthropists. She was then capable of reinstate two positions for at the least a 12 months — however job candidates are cautious.
Throughout the USA, the way forward for federal funding for most cancers analysis is unsure.
President Donald Trump has proposed slicing the NIH price range by practically 40% within the 2026 fiscal 12 months.
In a price range message, the White Home mentioned the “NIH has damaged the belief of the American folks with wasteful spending, deceptive data, dangerous analysis, and the promotion of harmful ideologies that undermine public well being.”
However Congress has different plans: The Senate and Home Appropriations Committees launched a compromise invoice on Jan. 20 that will set the NIH’s price range at $48.7 billion, $415 million greater than within the 2025 fiscal 12 months.
Within the meantime, advocates reminiscent of Mark Fleury with the American Most cancers Society are reminding lawmakers that the most cancers loss of life fee has declined — by 34% for the reason that early Nineties — due partly to federally funded analysis advances.
“However we nonetheless have an unimaginable methods to go earlier than we are able to say that we’ve modified the trajectory of most cancers,” Fleury mentioned. “There are nonetheless most cancers sorts which can be pretty deadly, and there are nonetheless populations of individuals for whom their expertise of most cancers is vastly totally different from different teams.”
Reductions in analysis funding can have a direct affect on therapy choices for sufferers, Fleury mentioned. For instance, a ten% lower to the NIH price range would finally end in two fewer new medicine or therapies per 12 months, in keeping with a projection from the nonpartisan Congressional Finances Workplace.
A latest examine checked out medicine that had been developed by NIH-funded analysis and permitted by the Meals and Drug Administration since 2000. Greater than half these medicine would most likely not have been developed if the NIH had been working with a 40% smaller price range.
“We will’t say, ‘However for that grant, that [specific] drug wouldn’t have come into existence,'” mentioned Pierre Azoulay, a co-author of the examine and a professor on the Massachusetts Institute of Know-how. However fewer medicine would have made it to market, he mentioned. “It makes us at the least wish to pause and say, ‘What are we doing right here? Are we capturing ourselves within the foot?'”
Amid all of the uncertainty, Brugge has bother specializing in her aim of discovering new methods to forestall breast most cancers.
These days, she spends about half her time looking for new sources of funding, managing her remaining workers’ anxieties, and monitoring the newest information about Harvard, the Trump administration, and the NIH and different federal businesses which have skilled grant freezes, workers layoffs, and different disruptions.
She’d relatively return her consideration to her ongoing investigations, which she’s assured may finally save lives.
The breakdown of Brugge’s lab highlights one other downside: The U.S. is kneecapping the subsequent technology of most cancers researchers. Her workers included workers scientists, postdocs, and graduate college students. Of the seven who left the lab in 2025, one left the U.S., one took a job at a well being care administration firm, 4 went again to high school, and one remains to be in search of work.
One in all Brugge’s former staffers, Y., is a computational biologist. She helped design and run a device that analyzes thousands and thousands of breast tissue cells from the samples within the pink-lidded jars.
Y. moved to Switzerland in October to start a PhD program. KFF Well being Information and NPR are figuring out her by her center preliminary as a result of she plans to return to the U.S. for scientific conferences and worries that talking publicly about her expertise may danger future visa approvals.
“I assumed the U.S. can be a protected place for scientists to study and develop,” mentioned Y., who moved to Boston from overseas for Harvard’s grasp’s diploma program in bioinformatics. “I actually hope that those that have the alternatives to review this additional can fill in these lacking items in most cancers analysis.”
Brugge is not accepting job candidates from outdoors the U.S., even when they’re prime candidates, as a result of she will be able to’t afford to pay the Trump administration’s new $100,000 charge on visas for some international researchers.
The Affiliation of American Universities and the U.S. Chamber of Commerce have filed a authorized problem, claiming the charge is misguided and unlawful. The Trump administration mentioned the charge would discourage reliance on international employees and enhance alternatives for Individuals.
Brugge doubts work in her lab will ever return to regular.
“There’ll at all times be, now, this existential menace to the analysis,” Brugge mentioned. “I’ll undoubtedly be involved as a result of we don’t know what’s going to occur sooner or later that may set off an analogous type of motion.”
Brugge has thought of shutting down her lab. However she nonetheless employs workers members whose future scientific careers are tied to ending a few of the analysis. And when she seems at these pink-lidded jars, she nonetheless sees a lot promise.
